.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Accenture
Novartis
Citi
Colorcon
Cantor Fitzgerald
McKinsey
Daiichi Sankyo
Argus Health
Merck

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074131

« Back to Dashboard

NDA 074131 describes PIROXICAM, which is a drug marketed by Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Mylan, Mylan Ireland Ltd, PII, SCS, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs, and is included in nineteen NDAs. It is available from twenty-four suppliers. Additional details are available on the PIROXICAM profile page.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the piroxicam profile page.

Summary for 074131

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074131

Medical Subject Heading (MeSH) Categories for 074131

Suppliers and Packaging for NDA: 074131

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PIROXICAM piroxicam CAPSULE;ORAL 074131 ANDA Teva Pharmaceuticals USA, Inc. 0093-0756 0093-0756-01 100 CAPSULE in 1 BOTTLE (0093-0756-01)
PIROXICAM piroxicam CAPSULE;ORAL 074131 ANDA Teva Pharmaceuticals USA, Inc. 0093-0757 0093-0757-05 500 CAPSULE in 1 BOTTLE (0093-0757-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Dec 11, 1992TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Dec 11, 1992TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Healthtrust
UBS
Fuji
Cantor Fitzgerald
Baxter
Fish and Richardson
Argus Health
Boehringer Ingelheim
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot